The present invention is directed to: a) a method of treating telangiectasia； b) a method of treating inflammatory lesions； and c) a method of treating two or more symptoms of rosacea selected from erythema, telangiectasia, or inflammatory lesions comprising topical administration of a pharmaceutical composition comprising oxymetazoline and a pharmaceutically acceptable excipient.
